{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:07:05Z","timestamp":1793156825276,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:00:00Z","timestamp":1710720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:00:00Z","timestamp":1710720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM128772"],"award-info":[{"award-number":["R35GM128772"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003085","name":"Longer Life Foundation","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100003085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["K08NS101118"],"award-info":[{"award-number":["K08NS101118"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Parkinson\u2019s disease (PD) is closely linked to \u03b1-synuclein (\u03b1-syn) misfolding and accumulation in Lewy bodies. The PDZ serine protease HTRA1 degrades fibrillar tau, which is associated with Alzheimer\u2019s disease, and inactivating mutations to mitochondrial HTRA2 are implicated in PD. Here, we report that HTRA1 inhibits aggregation of \u03b1-syn as well as FUS and TDP-43, which are implicated in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. The protease domain of HTRA1 is necessary and sufficient for inhibiting aggregation, yet this activity is proteolytically-independent. Further, HTRA1 disaggregates preformed \u03b1-syn fibrils, rendering them incapable of seeding aggregation of endogenous \u03b1-syn, while reducing HTRA1 expression promotes \u03b1-syn seeding. HTRA1 remodels \u03b1-syn fibrils by targeting the NAC domain, the key domain catalyzing \u03b1-syn amyloidogenesis. Finally, HTRA1 detoxifies \u03b1-syn fibrils and prevents formation of hyperphosphorylated \u03b1-syn accumulations in primary neurons. Our findings suggest that HTRA1 may be a therapeutic target for a range of neurodegenerative disorders.<\/jats:p>","DOI":"10.1038\/s41467-024-46538-8","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T14:02:21Z","timestamp":1710770541000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["HTRA1 disaggregates \u03b1-synuclein amyloid fibrils and converts them into non-toxic and seeding incompetent species"],"prefix":"10.1038","volume":"15","author":[{"given":"Sheng","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3642-728X","authenticated-orcid":false,"given":"Anuradhika","family":"Puri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Braxton","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Fritsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector H.","family":"Palacios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurie","family":"Balch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macy L.","family":"Sprunger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2128-2065","authenticated-orcid":false,"given":"Matthew K.","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0410-2456","authenticated-orcid":false,"given":"Jeremy J.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica N.","family":"Haines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3748-6193","authenticated-orcid":false,"given":"Gary J.","family":"Patti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2042-8445","authenticated-orcid":false,"given":"Albert A.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4406-9504","authenticated-orcid":false,"given":"Meredith E.","family":"Jackrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,18]]},"reference":[{"key":"46538_CR1","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/nm1113","volume":"10","author":"MS Forman","year":"2004","unstructured":"Forman, M. S., Trojanowski, J. Q. & Lee, V. M. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat. Med. 10, 1055\u20131063 (2004).","journal-title":"Nat. Med."},{"key":"46538_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41531-021-00203-9","volume":"7","author":"LMA Oliveira","year":"2021","unstructured":"Oliveira, L. M. A. et al. Alpha-synuclein research: defining strategic moves in the battle against Parkinson\u2019s disease. npj Parkinson\u2019s Dis. 7, 65 (2021).","journal-title":"npj Parkinson\u2019s Dis."},{"key":"46538_CR3","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/nature02261","volume":"426","author":"CM Dobson","year":"2003","unstructured":"Dobson, C. M. Protein folding and misfolding. Nature 426, 884\u2013890 (2003).","journal-title":"Nature"},{"key":"46538_CR4","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1227157","volume":"338","author":"KC Luk","year":"2012","unstructured":"Luk, K. C. et al. Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338, 949\u2013953 (2012).","journal-title":"Science"},{"key":"46538_CR5","doi-asserted-by":"publisher","first-page":"20051","DOI":"10.1073\/pnas.0908005106","volume":"106","author":"KC Luk","year":"2009","unstructured":"Luk, K. C. et al. Exogenous \u03b1-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc. Natl Acad. Sci. USA 106, 20051\u201320056 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"46538_CR6","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.cell.2012.02.022","volume":"148","author":"D Eisenberg","year":"2012","unstructured":"Eisenberg, D. & Jucker, M. The amyloid state of proteins in human diseases. Cell 148, 1188\u20131203 (2012).","journal-title":"Cell"},{"key":"46538_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature20413","volume":"539","author":"JP Taylor","year":"2016","unstructured":"Taylor, J. P., Brown, R. H. Jr., Cleveland, D. W. & Decoding, A. L. S. from genes to mechanism. Nature 539, 197\u2013206 (2016).","journal-title":"Nature"},{"key":"46538_CR8","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.3390\/biom11071014","volume":"11","author":"ML Sprunger","year":"2021","unstructured":"Sprunger, M. L. & Jackrel, M. E. Prion-like proteins in phase separation and their link to disease. Biomolecules 11, 1014 (2021).","journal-title":"Biomolecules"},{"key":"46538_CR9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","volume":"537","author":"J Sevigny","year":"2016","unstructured":"Sevigny, J. et al. The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease. Nature 537, 50\u201356 (2016).","journal-title":"Nature"},{"key":"46538_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2022","unstructured":"van Dyck, C. H. et al. Lecanemab in early Alzheimer\u2019s disease. N. Engl. J. Med. 388, 9\u201321 (2022).","journal-title":"N. Engl. J. Med."},{"key":"46538_CR11","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/d41586-023-00030-3","volume":"613","author":"S Reardon","year":"2023","unstructured":"Reardon, S. FDA approves Alzheimer\u2019s drug lecanemab amid safety concerns. Nature 613, 227\u2013228 (2023).","journal-title":"Nature"},{"key":"46538_CR12","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1056\/NEJMcibr065573","volume":"355","author":"RI Morimoto","year":"2006","unstructured":"Morimoto, R. I. Stress, aging, and neurodegenerative disease. N. Engl. J. Med 355, 2254\u20132255 (2006).","journal-title":"N. Engl. J. Med"},{"key":"46538_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1083\/jcb.201709072","volume":"217","author":"CL Klaips","year":"2017","unstructured":"Klaips, C. L., Jayaraj, G. G. & Hartl, F. U. Pathways of cellular proteostasis in aging and disease. J. Cell Biol. 217, 51\u201363 (2017).","journal-title":"J. Cell Biol."},{"key":"46538_CR14","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.4161\/cc.28709","volume":"13","author":"ME Jackrel","year":"2014","unstructured":"Jackrel, M. E. & Shorter, J. Reversing deleterious protein aggregation with re-engineered protein disaggregases. Cell Cycle 13, 1379\u20131383 (2014).","journal-title":"Cell Cycle"},{"key":"46538_CR15","doi-asserted-by":"crossref","unstructured":"Jackrel, M. E. & Shorter, J. Protein-remodeling factors as potential therapeutics for neurodegenerative disease. Front. Neurosci. 11, 99 (2017).","DOI":"10.3389\/fnins.2017.00099"},{"key":"46538_CR16","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1172\/JCI35781","volume":"118","author":"C Lo Bianco","year":"2008","unstructured":"Lo Bianco, C. et al. Hsp104 antagonizes \u03b1-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson\u2019s disease. J. Clin. Invest. 118, 3087\u20133097 (2008).","journal-title":"J. Clin. Invest."},{"key":"46538_CR17","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.cell.2012.09.038","volume":"151","author":"ME DeSantis","year":"2012","unstructured":"DeSantis, M. E. et al. Operational plasticity enables Hsp104 to disaggregate diverse amyloid and nonamyloid clients. Cell 151, 778\u2013793 (2012).","journal-title":"Cell"},{"key":"46538_CR18","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.1093\/hmg\/ddi372","volume":"14","author":"C Vacher","year":"2005","unstructured":"Vacher, C., Garcia-Oroz, L. & Rubinsztein, D. C. Overexpression of yeast hsp104 reduces polyglutamine aggregation and prolongs survival of a transgenic mouse model of Huntington\u2019s disease. Hum. Mol. Genet. 14, 3425\u20133433 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"46538_CR19","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.molcel.2015.07.012","volume":"59","author":"X Gao","year":"2015","unstructured":"Gao, X. et al. Human Hsp70 disaggregase reverses parkinson\u2019s-linked alpha-synuclein amyloid fibrils. Mol. Cell 59, 781\u2013793 (2015).","journal-title":"Mol. Cell"},{"key":"46538_CR20","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature14884","volume":"524","author":"NB Nillegoda","year":"2015","unstructured":"Nillegoda, N. B. et al. Crucial HSP70 co-chaperone complex unlocks metazoan protein disaggregation. Nature 524, 247\u2013251 (2015).","journal-title":"Nature"},{"key":"46538_CR21","doi-asserted-by":"publisher","first-page":"e26319","DOI":"10.1371\/journal.pone.0026319","volume":"6","author":"J Shorter","year":"2011","unstructured":"Shorter, J. The mammalian disaggregase machinery: Hsp110 synergizes with Hsp70 and Hsp40 to catalyze protein disaggregation and reactivation in a cell-free system. PLoS ONE 6, e26319 (2011).","journal-title":"PLoS ONE"},{"key":"46538_CR22","doi-asserted-by":"publisher","first-page":"eaay8826","DOI":"10.1126\/science.aay8826","volume":"370","author":"NF Darwich","year":"2020","unstructured":"Darwich, N. F. et al. Autosomal dominant VCP hypomorph mutation impairs disaggregation of PHF-tau. Science 370, eaay8826 (2020).","journal-title":"Science"},{"key":"46538_CR23","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41586-021-03824-5","volume":"597","author":"L Huang","year":"2021","unstructured":"Huang, L. et al. DAXX represents a new type of protein-folding enabler. Nature 597, 132\u2013137 (2021).","journal-title":"Nature"},{"key":"46538_CR24","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.cell.2018.03.002","volume":"173","author":"L Guo","year":"2018","unstructured":"Guo, L. et al. Nuclear-import receptors reverse aberrant phase transitions of RNA-binding proteins with prion-like domains. Cell 173, 677\u2013692.e620 (2018).","journal-title":"Cell"},{"key":"46538_CR25","doi-asserted-by":"publisher","first-page":"108418","DOI":"10.1016\/j.celrep.2020.108418","volume":"33","author":"G Zhu","year":"2020","unstructured":"Zhu, G. et al. TRIM11 prevents and reverses protein aggregation and rescues a mouse model of Parkinson\u2019s disease. Cell Rep. 33, 108418 (2020).","journal-title":"Cell Rep."},{"key":"46538_CR26","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/sj.cdd.4402291","volume":"15","author":"L Vande Walle","year":"2008","unstructured":"Vande Walle, L., Lamkanfi, M. & Vandenabeele, P. The mitochondrial serine protease HtrA2\/Omi: an overview. Cell Death Differ. 15, 453\u2013460 (2008).","journal-title":"Cell Death Differ."},{"key":"46538_CR27","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/nrm3065","volume":"12","author":"T Clausen","year":"2011","unstructured":"Clausen, T., Kaiser, M., Huber, R. & Ehrmann, M. HTRA proteases: regulated proteolysis in protein quality control. Nat. Rev. Mol. Cell Biol. 12, 152\u2013162 (2011).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"46538_CR28","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nchembio.1931","volume":"11","author":"S Poepsel","year":"2015","unstructured":"Poepsel, S. et al. Determinants of amyloid fibril degradation by the PDZ protease HTRA1. Nat. Chem. Biol. 11, 862\u2013869 (2015).","journal-title":"Nat. Chem. Biol."},{"key":"46538_CR29","doi-asserted-by":"publisher","first-page":"7702","DOI":"10.1073\/pnas.0803392105","volume":"105","author":"T Krojer","year":"2008","unstructured":"Krojer, T. et al. Interplay of PDZ and protease domain of DegP ensures efficient elimination of misfolded proteins. Proc. Natl Acad. Sci. USA 105, 7702\u20137707 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"46538_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14208-z","volume":"7","author":"AC Cabrera","year":"2017","unstructured":"Cabrera, A. C. et al. HtrA1 activation is driven by an allosteric mechanism of inter-monomer communication. Sci. Rep. 7, 14804 (2017).","journal-title":"Sci. Rep."},{"key":"46538_CR31","doi-asserted-by":"publisher","first-page":"e2113520119","DOI":"10.1073\/pnas.2113520119","volume":"119","author":"J Rey","year":"2022","unstructured":"Rey, J. et al. An allosteric HTRA1-calpain 2 complex with restricted activation profile. Proc. Natl Acad. Sci. USA 119, e2113520119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"46538_CR32","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1110\/ps.073049407","volume":"16","author":"ST Runyon","year":"2007","unstructured":"Runyon, S. T. et al. Structural and functional analysis of the PDZ domains of human HtrA1 and HtrA3. Protein Sci. 16, 2454\u20132471 (2007).","journal-title":"Protein Sci."},{"key":"46538_CR33","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1093\/hmg\/ddi215","volume":"14","author":"KM Strauss","year":"2005","unstructured":"Strauss, K. M. et al. Loss of function mutations in the gene encoding Omi\/HtrA2 in Parkinson\u2019s disease. Hum. Mol. Genet. 14, 2099\u20132111 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"46538_CR34","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1128\/MCB.00035-09","volume":"29","author":"J Chien","year":"2009","unstructured":"Chien, J. et al. Serine protease HtrA1 associates with microtubules and inhibits cell migration. Mol. Cell. Biol. 29, 4177\u20134187 (2009).","journal-title":"Mol. Cell. Biol."},{"key":"46538_CR35","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1126\/science.1079469","volume":"300","author":"R Kayed","year":"2003","unstructured":"Kayed, R. et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486\u2013489 (2003).","journal-title":"Science"},{"key":"46538_CR36","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.tibs.2020.11.007","volume":"46","author":"AB Malpartida","year":"2021","unstructured":"Malpartida, A. B., Williamson, M., Narendra, D. P., Wade-Martins, R. & Ryan, B. J. Mitochondrial dysfunction and mitophagy in parkinson\u2019s disease: from mechanism to therapy. Trends Biochem. Sci. 46, 329\u2013343 (2021).","journal-title":"Trends Biochem. Sci."},{"key":"46538_CR37","doi-asserted-by":"publisher","first-page":"20329","DOI":"10.1074\/jbc.M109.010264","volume":"284","author":"BS Johnson","year":"2009","unstructured":"Johnson, B. S. et al. TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J. Biol. Chem. 284, 20329\u201320339 (2009).","journal-title":"J. Biol. Chem."},{"key":"46538_CR38","doi-asserted-by":"publisher","first-page":"e1000614","DOI":"10.1371\/journal.pbio.1000614","volume":"9","author":"Z Sun","year":"2011","unstructured":"Sun, Z. et al. Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS\/TLS. PLoS Biol. 9, e1000614 (2011).","journal-title":"PLoS Biol."},{"key":"46538_CR39","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1038\/nprot.2014.143","volume":"9","author":"LA Volpicelli-Daley","year":"2014","unstructured":"Volpicelli-Daley, L. A., Luk, K. C. & Lee, V. M. Addition of exogenous \u03b1-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous \u03b1-synuclein to Lewy body and Lewy neurite-like aggregates. Nat. Protoc. 9, 2135\u20132146 (2014).","journal-title":"Nat. Protoc."},{"key":"46538_CR40","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nrn3430","volume":"14","author":"W Robberecht","year":"2013","unstructured":"Robberecht, W. & Philips, T. The changing scene of amyotrophic lateral sclerosis. Nat. Rev. Neurosci. 14, 248\u2013264 (2013).","journal-title":"Nat. Rev. Neurosci."},{"key":"46538_CR41","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/3311","volume":"4","author":"KA Conway","year":"1998","unstructured":"Conway, K. A., Harper, J. D. & Lansbury, P. T. Accelerated in vitro fibril formation by a mutant \u03b1-synuclein linked to early-onset Parkinson\u2019s disease. Nat. Med. 4, 1318\u20131320 (1998).","journal-title":"Nat. Med."},{"key":"46538_CR42","doi-asserted-by":"publisher","first-page":"a024026","DOI":"10.1101\/cshperspect.a024026","volume":"7","author":"BB Holmes","year":"2017","unstructured":"Holmes, B. B. & Diamond, M. I. Cellular models for the study of prions. Cold Spring Harb. Perspect. Med. 7, a024026 (2017).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"46538_CR43","doi-asserted-by":"publisher","first-page":"E4376","DOI":"10.1073\/pnas.1411649111","volume":"111","author":"BB Holmes","year":"2014","unstructured":"Holmes, B. B. et al. Proteopathic tau seeding predicts tauopathy in vivo. Proc. Natl Acad. Sci. USA 111, E4376\u2013E4385 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"46538_CR44","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1074\/jbc.M008919200","volume":"276","author":"BI Giasson","year":"2001","unstructured":"Giasson, B. I., Murray, I. V. J., Trojanowski, J. Q. & Lee, V. M. Y. A hydrophobic stretch of 12 amino acid residues in the middle of \u03b1-synuclein is essential for filament assembly. J. Biol. Chem. 276, 2380\u20132386 (2001).","journal-title":"J. Biol. Chem."},{"key":"46538_CR45","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.str.2012.03.021","volume":"20","author":"C Eigenbrot","year":"2012","unstructured":"Eigenbrot, C. et al. Structural and functional analysis of HtrA1 and its subdomains. Structure 20, 1040\u20131050 (2012).","journal-title":"Structure"},{"key":"46538_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-18203-2","volume":"7","author":"O Globus","year":"2017","unstructured":"Globus, O., Evron, T., Caspi, M., Siman-Tov, R. & Rosin-Arbesfeld, R. High-temperature requirement A1 (Htra1) - a novel regulator of canonical Wnt signaling. Sci. Rep. 7, 17995 (2017).","journal-title":"Sci. Rep."},{"key":"46538_CR47","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara, H. et al. alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell Biol. 4, 160\u2013164 (2002).","journal-title":"Nat. Cell Biol."},{"key":"46538_CR48","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.cell.2013.11.047","volume":"156","author":"ME Jackrel","year":"2014","unstructured":"Jackrel, M. E. et al. Potentiated Hsp104 variants antagonize diverse proteotoxic misfolding events. Cell 156, 170\u2013182 (2014).","journal-title":"Cell"},{"key":"46538_CR49","first-page":"1175","volume":"7","author":"ME Jackrel","year":"2014","unstructured":"Jackrel, M. E. & Shorter, J. Potentiated Hsp104 variants suppress toxicity of diverse neurodegenerative disease-linked proteins. Dis. Model Mech. 7, 1175\u20131184 (2014).","journal-title":"Dis. Model Mech."},{"key":"46538_CR50","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1021\/acschembio.5b00765","volume":"10","author":"ME Jackrel","year":"2015","unstructured":"Jackrel, M. E., Yee, K., Tariq, A., Chen, A. I. & Shorter, J. Disparate mutations confer therapeutic gain of Hsp104 function. ACS Chem. Biol. 10, 2672\u20132679 (2015).","journal-title":"ACS Chem. Biol."},{"key":"46538_CR51","doi-asserted-by":"publisher","first-page":"11286","DOI":"10.1074\/jbc.RA119.009494","volume":"294","author":"JJ Ryan","year":"2019","unstructured":"Ryan, J. J., Sprunger, M. L., Holthaus, K., Shorter, J. & Jackrel, M. E. Engineered protein disaggregases mitigate toxicity of aberrant prion-like fusion proteins underlying sarcoma. J. Biol. Chem. 294, 11286\u201311296 (2019).","journal-title":"J. Biol. Chem."},{"key":"46538_CR52","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1016\/j.celrep.2019.07.069","volume":"28","author":"A Tariq","year":"2019","unstructured":"Tariq, A. et al. Mining disaggregase sequence space to safely counter TDP-43, FUS, and \u03b1-synuclein proteotoxicity. Cell Rep. 28, 2080\u20132095.e2086 (2019).","journal-title":"Cell Rep."},{"key":"46538_CR53","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1083\/jcb.201608022","volume":"216","author":"K Yasuda","year":"2017","unstructured":"Yasuda, K., Clatterbuck-Soper, S. F., Jackrel, M. E., Shorter, J. & Mili, S. FUS inclusions disrupt RNA localization by sequestering kinesin-1 and inhibiting microtubule detyrosination. J. Cell Biol. 216, 1015\u20131034 (2017).","journal-title":"J. Cell Biol."},{"key":"46538_CR54","doi-asserted-by":"publisher","first-page":"103900","DOI":"10.1016\/j.isci.2022.103900","volume":"25","author":"ML Sprunger","year":"2022","unstructured":"Sprunger, M. L., Lee, K., Sohn, B. S. & Jackrel, M. E. Molecular determinants and modifiers of Matrin-3 toxicity, condensate dynamics, and droplet morphology. iScience 25, 103900 (2022).","journal-title":"iScience"},{"key":"46538_CR55","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1080\/19336896.2015.1020277","volume":"9","author":"ME Jackrel","year":"2015","unstructured":"Jackrel, M. E. & Shorter, J. Engineering enhanced protein disaggregases for neurodegenerative disease. Prion 9, 90\u2013109 (2015).","journal-title":"Prion"},{"key":"46538_CR56","doi-asserted-by":"publisher","first-page":"9473","DOI":"10.1021\/jacs.6b03463","volume":"138","author":"Q Chu","year":"2016","unstructured":"Chu, Q. et al. HtrA1 proteolysis of ApoE in vitro is allele selective. J. Am. Chem. Soc. 138, 9473\u20139478 (2016).","journal-title":"J. Am. Chem. Soc."},{"key":"46538_CR57","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1021\/bi020429y","volume":"42","author":"JC Kessler","year":"2003","unstructured":"Kessler, J. C., Rochet, J. C. & Lansbury, P. T. Jr. The N-terminal repeat domain of alpha-synuclein inhibits beta-sheet and amyloid fibril formation. Biochemistry 42, 672\u2013678 (2003).","journal-title":"Biochemistry"},{"key":"46538_CR58","doi-asserted-by":"publisher","first-page":"e97452","DOI":"10.15252\/embj.201797452","volume":"37","author":"A Wang","year":"2018","unstructured":"Wang, A. et al. A single N-terminal phosphomimic disrupts TDP-43 polymerization, phase separation, and RNA splicing. EMBO J. 37, e97452 (2018).","journal-title":"EMBO J."},{"key":"46538_CR59","doi-asserted-by":"crossref","unstructured":"Shrimali, P. et al. Amyloidogenic propensity of self-assembling peptides and their adjuvant potential for use as DNA vaccines. Acta Biomater. 169, 464\u2013476 (2023).","DOI":"10.1016\/j.actbio.2023.08.015"},{"key":"46538_CR60","doi-asserted-by":"publisher","first-page":"D1107","DOI":"10.1093\/nar\/gkw1080","volume":"45","author":"S Okuda","year":"2017","unstructured":"Okuda, S. et al. jPOSTrepo: an international standard data repository for proteomes. Nucleic Acids Res. 45, D1107\u2013d1111 (2017).","journal-title":"Nucleic Acids Res."},{"key":"46538_CR61","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1074\/jbc.RA118.004471","volume":"294","author":"TR Yamasaki","year":"2019","unstructured":"Yamasaki, T. R. et al. Parkinson\u2019s disease and multiple system atrophy have distinct \u03b1-synuclein seed characteristics. J. Biol. Chem. 294, 1045\u20131058 (2019).","journal-title":"J. Biol. Chem."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-46538-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-46538-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-46538-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T14:04:51Z","timestamp":1710770691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-46538-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,18]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["46538"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-46538-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2570571\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,18]]},"assertion":[{"value":"9 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.J.P. has a collaborative research agreement with ThermoFisher Scientific and is the Chief Scientific Officer of Panome Bio. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2436"}}